Evidence map›Paper›PMID 25930247›Full record

ArticleAnnals of surgical oncology2015

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

Shoshana M Rosenberg, Karen Sepucha, Kathryn J Ruddy, Rulla M Tamimi, Shari Gelber, Meghan E Meyer, Lidia Schapira, Steven E Come, Virginia F Borges, Mehra Golshan and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Annals of surgical oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01468246 (Helping Ourselves, Helping Others), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01468246 active not recruitingnot on this map

Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study

TypeobservationalSponsorDana-Farber Cancer InstituteRan2006 to 2035Enrolled1,302ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Shoshana M RosenbergDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Karen SepuchaDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Kathryn J RuddyDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Rulla M TamimiChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Shari GelberDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Meghan E MeyerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Lidia SchapiraDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Steven E ComeDepartment of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Virginia F BorgesDivision of Medical Oncology, University of Colorado, Aurora, CO, USA.
Mehra GolshanDepartment of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Eric P WinerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ann H PartridgeDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ahpartridge@partners.org.
Dana-Farber Cancer Institute · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USBoston University · USMassachusetts General Hospital · USMayo Clinic in Arizona · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Harvard Education Program in Cancer Prevention Control (R25T)R25CA057711 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI DAVISON, KIRSTEN · 1992 to 2018
$8.5M
NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
NCI NIH HHS R01 CA169175NCI NIH HHS R25 CA057711
6 · The paper itself

Abstract

backgroundRates of contralateral prophylactic mastectomy (CPM) have increased in the United States, with younger women with breast cancer the most likely to have CPM.

methodsAs part of an ongoing cohort study of young women diagnosed with breast cancer at age ≤40 years, we conducted multinomial logistic regression of data from 560 women with unilateral Stage I-III disease to identify factors associated with: (1) CPM versus unilateral mastectomy (UM); (2) CPM versus breast-conserving surgery (BCS).

resultsMedian age at diagnosis was 37 years; 66 % of women indicated that their doctor said that BCS was an option or was recommended. Of all women, 42.9 % had CPM, 26.8 % UM, and 30.4 % BCS. Among women who said the surgical decision was patient-driven, 59.9 % had CPM, 22.8 % BCS, and 17.3 % UM. Clinical characteristics associated with CPM versus BCS included HER2 positivity, nodal involvement, larger tumor size, lower BMI, parity, and testing positive for a BRCA mutation. Emotional and decisional factors associated with CPM versus UM and BCS included anxiety, less fear of recurrence, and reporting a patient-driven decision. Women who reported a physician-driven decision were less likely to have had CPM than both of the other surgeries, whereas higher confidence with the decision was associated with having CPM versus BCS.

conclusionsMany young women with early-stage breast cancer are choosing CPM. The association between CPM and emotional and decisional factors suggest that improved communication together with better psychosocial support may improve the decision-making process.

Indexed as

Decision MakingMastectomy, SegmentalPatient ParticipationAdolescentAdultAnxietyBody Mass IndexBreast NeoplasmsDirective CounselingErb-b2 Receptor Tyrosine KinasesFearFemaleGenes, BRCA1Genes, BRCA2Genetic TestingHumansERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID25930247
PMCPMC4598267
OpenAlexW2065820041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.